Hybrid vs. Center-based Cardiac Rehabilitation for Cardiovascular Disease

Recruiting at 8 trial locations

Overseen By Mathieu Bélanger

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Université de Sherbrooke

Disqualifiers: Physical or cognitive conditions, prior CR, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 12

Duration: 12 weeks

278 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Hybrid Cardiac Rehabilitation Intervention for cardiovascular disease?

Research shows that hybrid cardiac rehabilitation, which combines center-based and home-based exercises, can improve exercise capacity and quality of life in patients with heart conditions like coronary artery disease and heart failure. It also leads to similar short-term outcomes as traditional center-based programs, with increased adherence and reduced costs. ^{1 2 3 4 5}

Is hybrid cardiac rehabilitation safe for humans?

Hybrid cardiac rehabilitation, which combines center-based and home-based exercise, has been studied in various patient groups and is generally considered safe. Studies have shown it can improve exercise capacity and quality of life without significant safety concerns. ^{1 2 3 4 6}

How does hybrid cardiac rehabilitation treatment differ from other treatments for cardiovascular disease?

Hybrid cardiac rehabilitation combines supervised sessions at a center with monitored exercises at home, making it more flexible and accessible than traditional center-based programs. This approach can improve adherence, reduce costs, and maintain or enhance health outcomes like exercise capacity and quality of life. ^{1 2 3 4 7}

What is the purpose of this trial?

The goal of this pragmatic randomized clinical trial is to compare the effectiveness of a hybrid model of cardiac rehabilitation with a centre-based program in people with cardiovascular disease. The main question it aims to answer is: • How effective is a hybrid model of CR for people with cardiovascular disease living in a francophone minority community compared to a centre-based model of CR in terms of leading to maintenance of gains (physical activity level, functional capacity, mental health, quality of life) six months after CR? Participants will undergo a 12-week hybrid cardiac rehabilitation program. For the first six weeks, patients will be required to attend the hospital twice a week. After that, there will be a gradual increase in home sessions for the remaining six weeks. When a patient has a home session, health professionals will follow up with a weekly phone call. Researchers will compare the centre-based cardiac rehabilitation program with the hybrid program to see if the hybrid program can better maintain the level of physical activity, mental health, functional capacity, and quality of life six months after the end of the program.

Research Team

Pamela Tanguay

Principal Investigator

Université de Sherbrooke

Eligibility Criteria

This trial is for adults over 19 with cardiovascular disease who are eligible for the Vitalité Health Network Cardiac rehabilitation program. It's not specified who can't join, so it may be open to many people.

Inclusion Criteria

I am eligible for the Vitalité Cardiac Rehab program.

I am over 19 years old.

Exclusion Criteria

I cannot join an exercise program due to a physical or mental condition.

Have previously participated in a Cardiac Rehabilitation (CR) program.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a 12-week hybrid cardiac rehabilitation program. For the first six weeks, patients attend the hospital twice a week, followed by a gradual increase in home sessions with weekly phone follow-ups for the remaining six weeks.

12 weeks

12 visits (in-person), 6 phone follow-ups

Follow-up

Participants are monitored for maintenance of physical activity, functional capacity, mental health, and quality of life six months after the end of the program.

6 months

Treatment Details

Interventions

• Center-based Cardiac Rehabilitation Intervention
• Hybrid Cardiac Rehabilitation Intervention

Trial Overview The study compares a hybrid cardiac rehab program (partly at hospital, partly at home) with a traditional center-based one. The focus is on whether the hybrid approach better maintains health benefits six months post-rehab.

Participant Groups

Group I: Hybrid cardiac rehabilitation program Experimental Treatment 1 Intervention

Group II: Center-based cardiac rehabilitation program Active Control 1 Intervention

Who Is Running the Clinical Trial?

Université de Sherbrooke

Lead Sponsor

Trials

317

Recruited

79,300+

References

1. United States pubmed.ncbi.nlm.nih.gov

Hybrid cardiac rehabilitation - The state of the science and the way forward. [2022]

2. United States pubmed.ncbi.nlm.nih.gov

Traditional vs Extended Hybrid Cardiac Rehabilitation Based on the Continuous Care Model for Patients Who Have Undergone Coronary Artery Bypass Surgery in a Middle-Income Country: A Randomized Controlled Trial. [2021]

3. Switzerland pubmed.ncbi.nlm.nih.gov

Importance of Completing Hybrid Cardiac Rehabilitation for Long-Term Outcomes: A Real-World Evaluation. [2020]

4. United States pubmed.ncbi.nlm.nih.gov

A Comparison of Exercise Intensity in Hybrid Versus Standard Phase Two Cardiac Rehabilitation. [2023]

5. England pubmed.ncbi.nlm.nih.gov

Home-Based Cardiac Rehabilitation Alone and Hybrid With Center-Based Cardiac Rehabilitation in Heart Failure: A Systematic Review and Meta-Analysis. [2021]

6. Poland pubmed.ncbi.nlm.nih.gov

Hybrid model of cardiac rehabilitation in men and women after myocardial infarction. [2022]

7. Korea (South) pubmed.ncbi.nlm.nih.gov

A hybrid cardiac rehabilitation is as effective as a hospital-based program in reducing chest pain intensity and discomfort. [2022]